|
|
Am J Pathol. 1992 February; 140(2): 417–425. | PMCID: PMC1886421 |
Vascular expression of glucose transporter in experimental brain neoplasms. C. Guerin, J. Laterra, L. R. Drewes, H. Brem, and G. W. Goldstein Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. Abstract Vascular abnormalities in brain neoplasms are important to tumor biology and therapy. Glucose transporter (GLUT1) expression is a differentiated property of normal cerebral microvessels typically associated with expression of the blood-brain barrier. We investigated the relationship of GLUT1 expression to other vascular characteristics in F98, 9L, and C6 gliomas and Walker 256 carcinomas implanted into adult rat brains. The percentages of microvessels with immunohistochemically detectable GLUT1 were 95.5 +/- 3.9 in F98, 60.9 +/- 3.9 in 9L, 45.4 +/- 5.6 in C6, and 1.2 +/- 0.3 in Walker 256 (mean +/- SEM). The percentage of GLUT1-positive vessels in F98 was not statistically different from that in normal brain. GLUT1 expression was not dependent on restricted permeability as all tumors were highly permeable to Evans blue. GLUT1 expression was unrelated to vascular density, vascular morphology, and parenchymal GFAP expression. The expression of GLUT1, a marker of cerebral endothelial differentiation, is a newly described property of glial tumor vessels that may have diagnostic and prognostic significance. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Images in this article Click on the image to see a larger version. These references are in PubMed. This may not be the complete list of references from this article. - Silverman C, Marks JE. Prognostic significance of contrast enhancement in low-grade astrocytomas of the adult cerebrum. Radiology. 1981 Apr;139(1):211–213. [PubMed]
- Butler AR, Horii SC, Kricheff II, Shannon MB, Budzilovich GN. Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan. Radiology. 1978 Nov;129(2):433–439. [PubMed]
- Long DM. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg. 1970 Feb;32(2):127–144. [PubMed]
- Shibata S. Ultrastructure of capillary walls in human brain tumors. Acta Neuropathol. 1989;78(6):561–571. [PubMed]
- Debbage PL, Gabius HJ, Bise K, Marguth F. Cellular glycoconjugates and their potential endogenous receptors in the cerebral microvasculature of man: a glycohistochemical study. Eur J Cell Biol. 1988 Aug;46(3):425–434. [PubMed]
- O'Connor JS, Laws ER., Jr Changes in histochemical staining of brain tumor blood vessels associated with increasing malignancy. Acta Neuropathol. 1969;14(3):161–173. [PubMed]
- Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 1967 Jul;34(1):207–217. [PubMed]
- Goldstein GW, Betz AL. The blood-brain barrier. Sci Am. 1986 Sep;255(3):74–83. [PubMed]
- Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR. Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res. 1989 Apr;22(4):464–472. [PubMed]
- Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI. The glucose transporter of the human brain and blood-brain barrier. Ann Neurol. 1988 Dec;24(6):757–764. [PubMed]
- Pardridge WM, Boado RJ, Farrell CR. Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem. 1990 Oct 15;265(29):18035–18040. [PubMed]
- Harik SI, Kalaria RN, Andersson L, Lundahl P, Perry G. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci. 1990 Dec;10(12):3862–3872. [PubMed]
- Takata K, Kasahara T, Kasahara M, Ezaki O, Hirano H. Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers. Biochem Biophys Res Commun. 1990 Nov 30;173(1):67–73. [PubMed]
- Guerin C, Laterra J, Hruban RH, Brem H, Drewes LR, Goldstein GW. The glucose transporter and blood-brain barrier of human brain tumors. Ann Neurol. 1990 Dec;28(6):758–765. [PubMed]
- Ko L, Koestner A, Wechsler W. Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol. 1980;51(1):23–31. [PubMed]
- Schmidek HH, Nielsen SL, Schiller AL, Messer J. Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg. 1971 Mar;34(3):335–340. [PubMed]
- Benda P, Lightbody J, Sato G, Levine L, Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 1968 Jul 26;161(839):370–371. [PubMed]
- Bissell MG, Rubinstein LJ, Bignami A, Herman MM. Characteristics of the rat C-6 glioma maintained in organ culture systems. Production of glial fibrillary acidic protein in the absence of gliofibrillogenesis. Brain Res. 1974 Dec 20;82(1):77–89. [PubMed]
- Giordana MT, Germano I, Giaccone G, Mauro A, Migheli A, Schiffer D. The distribution of laminin in human brain tumors: an immunohistochemical study. Acta Neuropathol. 1985;67(1-2):51–57. [PubMed]
- Eriksdotter-Nilsson M, Björklund H, Olson L. Laminin immunohistochemistry: a simple method to visualize and quantitate vascular structures in the mammalian brain. J Neurosci Methods. 1986 Sep;17(4):275–286. [PubMed]
- Gerhart DZ, Drewes LR. Glucose transporters at the blood-nerve barrier are associated with perineurial cells and endoneurial microvessels. Brain Res. 1990 Jan 29;508(1):46–50. [PubMed]
- Harik SI, Roessmann U. The erythrocyte-type glucose transporter in blood vessels of primary and metastatic brain tumors. Ann Neurol. 1991 May;29(5):487–491. [PubMed]
- Svendgaard NA, Björklund A, Hardebo JE, Stenevi U. Axonal degeneration associated with a defective blood-brain barrier in cerebral implants. Nature. 1975 May 22;255(5506):334–336. [PubMed]
- Stewart PA, Wiley MJ. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras. Dev Biol. 1981 May;84(1):183–192. [PubMed]
- Janzer RC, Raff MC. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 325(6101):253–257. [PubMed]
- DeBault LE, Cancilla PA. gamma-Glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro. Science. 1980 Feb 8;207(4431):653–655. [PubMed]
- Tao-Cheng JH, Brightman MW. Development of membrane interactions between brain endothelial cells and astrocytes in vitro. Int J Dev Neurosci. 1988;6(1):25–37. [PubMed]
- Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst. 1972 Feb;48(2):347–356. [PubMed]
- Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991 Jan 3;324(1):1–8. [PubMed]
- Seitz RJ, Deckert M, Wechsler W. Vascularization of syngenic intracerebral RG2 and F98 rat transplantation tumors. A histochemical and morphometric study by use of ricinus communis agglutinin I. Acta Neuropathol. 1988;76(6):599–605. [PubMed]
|
This article has been 
